News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

October 2014

Top

Daiichi Sankyo to buy Ambit Biosciences for $410m
01 October 2014 Japan-based Daiichi Sankyo has signed an agreement to acquire US-based Ambit Biosciences, for $410m....

Afatinib drug could inhibit growth of womb cancer, say Yale scientists
01 October 2014 Research conducted by scientists from the Yale School of Medicine gynaecologic oncology division has demonstrated that the drug afatinib could inhibit the growth of womb cancer and shrink tumours....

September 2014

Top

Leiden University research team receives grant to develop bladder cancer treatment
30 September 2014 A team led by Dr Gabri van der Pluijm from Netherlands Leiden University Medical Centre has received $150,000 Uro-Oncology Grant from the Astellas European Foundation....

Amag Pharmaceuticals to buy Lumara Health for $675m
30 September 2014 Amag Pharmaceuticals has signed an agreement to acquire a privately held maternal health pharmaceutical company, Lumara Health, for $675m....

AbbVie’s Humira receives FDA approval to treat Crohn’s disease in paediatric patients
29 September 2014 AbbVie has received approval from the US Food and Drug Administration (FDA) for its Humira (adalimumab) to treat paediatric patients with moderately to severely active Crohn’s disease....

Roche’s Perjeta breast cancer drug shows extended survival benefit
29 September 2014 Roche’s breast cancer drug Perjeta (pertuzumab) has shown extended survival benefits in patients with previously untreated HER2-positive metastatic breast cancer....

Thermo Fisher collaborates with GSK and Pfizer to develop NGS oncology test
26 September 2014 Thermo Fisher Scientific has signed an agreement with GlaxoSmithKline (GSK) and Pfizer to develop a universal next-generation sequencing (NGS) oncology test for solid tumours, which will be used...

Rexahn’s RX-3117 obtains FDA orphan drug designation
26 September 2014 Rexahn Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its RX-3117 drug used to treat patients with pancreatic cancer....

Baxter and Merrimack partner to develop nanoliposomal irinotecan injection
25 September 2014 US-based Baxter International has entered into an exclusive license and collaboration agreement with Merrimack Pharmaceuticals to develop and commercialise MM-398 (nanoliposomal...

Brazilian researchers releases dengue-blocking mosquitoes
25 September 2014 Brazilian researchers have released mosquitoes infected with dengue-blocking bacteria as part of the 'Eliminate the dengue: Challenge Brazil' project to fight against fever through a natural means....

Statins increase risk of type 2 diabetes and bodyweight, say researchers
24 September 2014 Researchers from University College London (UCL) and the University of Glasgow have investigated and concluded that statins have a modest effect in increasing the risk of type 2 diabetes...

Bayer’s Eylea receives Japanese approval to treat myopic CNV
24 September 2014 Bayer HealthCare has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its Eylea (aflibercept solution for injection) to treat patients with myopic...

UK researchers discover new gene responsible for serious respiratory infections
23 September 2014 Researchers from the University College London have discovered a new gene associated to a rare disease, which induces respiratory problems similar to cystic fibrosis....

Merck to buy Sigma-Aldrich for $17bn
23 September 2014 US-based Merck has signed an agreement to acquire Sigma-Aldrich for $17bn (€13.1bn), which will boost the company's position in the life science industry....

GSK to pay £297m fine over bribery case in China
22 September 2014 GlaxoSmithKline (GSK) has been fined £297m by the Changsha Intermediate People's Court in Hunan Province, China, over bribery charges....

Gilead’s Zydelig gets marketing approval from European Commission for incurable blood cancers
22 September 2014 US-based Gilead Sciences has received marketing authorisation from the European Commission for its Zydelig (idelalisib) 150mg tablets to treat two incurable blood cancers, chronic...

Boehringer Ingelheim and CureVac to develop lung cancer immunotherapy
19 September 2014 Germany-based Boehringer Ingelheim has entered an exclusive global licence and development collaboration with CureVac to develop lung cancer immunotherapy....

Sun Pharma and Merck partner for plaque psoriasis drug candidate tildrakizumab
19 September 2014 India-based Sun Pharma has signed an exclusive worldwide licensing agreement with US-based Merck for its investigational therapeutic antibody candidate, tildrakizumab (MK-3222)....

AstraZeneca’s Movantik receives FDA approval to treat OIC
18 September 2014 AstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Movantik (naloxegol) tablets C-II to treat opioid-induced constipation (OIC) in adult patients with...

Sanofi and MyoKardia partner to develop treatments for heritable heart diseases
18 September 2014 France-based Sanofi has partnered with US-based MyoKardia to discover and develop targeted therapeutics to treat patients with genetic heart disease....

MedGenesis and Pfizer partner for Parkinson's disease treatments
17 September 2014 US-based Pfizer has collaborated with Canada-based MedGenesis Therapeutixon on potential treatments for Parkinson's...